[1]
“Outcome of Well-Differentiated Thyroid Carcinoma Patients Receiving a Cumulative Doses of ? 600 mCi (22GBq) of I-131”, Bangladesh J. Nuclear Med., vol. 17, no. 2, pp. 114–119, Jun. 2016, doi: 10.3329/bjnm.v17i2.28195.